Beta Bionics, Inc.
BBNX
$10.20
$0.303.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.99% | 17.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.99% | 17.86% | |||
| Cost of Revenue | -15.09% | 8.60% | |||
| Gross Profit | -13.23% | 25.30% | |||
| SG&A Expenses | 21.71% | 4.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.57% | 8.92% | |||
| Operating Income | -50.53% | 5.39% | |||
| Income Before Tax | -62.59% | 5.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -62.59% | 5.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -62.59% | 5.23% | |||
| EBIT | -50.53% | 5.39% | |||
| EBITDA | -51.97% | 6.44% | |||
| EPS Basic | -61.70% | 6.42% | |||
| Normalized Basic EPS | -61.76% | 6.44% | |||
| EPS Diluted | -61.70% | 6.42% | |||
| Normalized Diluted EPS | -61.76% | 6.44% | |||
| Average Basic Shares Outstanding | 0.55% | 1.28% | |||
| Average Diluted Shares Outstanding | 0.55% | 1.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||